You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203479

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 203479 describes VERSACLOZ, which is a drug marketed by Tasman Pharma and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the VERSACLOZ profile page.

The generic ingredient in VERSACLOZ is clozapine. There are thirteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the clozapine profile page.
Summary for 203479
Applicant:Tasman Pharma
Formulation / Manufacturing:see details
Pharmacology for NDA: 203479
Medical Subject Heading (MeSH) Categories for 203479
Suppliers and Packaging for NDA: 203479
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VERSACLOZ clozapine SUSPENSION;ORAL 203479 NDA TruPharma LLC 52817-601 52817-601-38 1 BOTTLE in 1 BOX (52817-601-38) > 100 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrength50MG/ML
Approval Date:Feb 6, 2013TE:RLD:Yes
Patent:  Start TrialPatent Expiration:May 1, 2028Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.